Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy
Completed
Takeda
N/A
2007-10-01
The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by
the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the
prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and
size of polyps detected on examination.
Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy
Completed
Brooke Army Medical Center
N/A
2007-10-01
The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by
the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the
prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and
size of polyps detected on examination.
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
Completed
Takeda
Phase 3
2007-12-01
The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone
administration in participants with opioid-induced bowel dysfunction.
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
Completed
Sucampo Pharma Americas, LLC
Phase 3
2007-12-01
The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone
administration in participants with opioid-induced bowel dysfunction.
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
Completed
Sucampo Pharmaceuticals, Inc.
Phase 3
2007-12-01
The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone
administration in participants with opioid-induced bowel dysfunction.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
